Monterey Bio Acquisition Corporation
MTRY
MTRYMonterey Bio Acquisition Corporation
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Mr. Murat Omur
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 17 State Street New York NY United States of America 10004
- IPO Date
- Nov 22, 2021
- CIK
- 0001860663
- Website
- montereybio.com
- Similar Companies
- Business
- Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.